- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06630676
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Artificial intelligence (AI), the growth of the internet and internet access, direct-to-patient advertising, and more recently the COVID-19 pandemic with a proliferation of telehealth visits has transformed medicine. Patients come in with a wealth of information, some accurate but some inaccurate, about their condition, often with preconceived notions about what condition they have and how they want to be treated. For conditions such as chronic pain with a high prevalence rate of abnormal imaging findings in asymptomatic individuals, the absence of biomarkers for clear-cut diagnoses, and subjective outcome measures, this has led to unnecessary tests and treatment, doctor shopping, high rates of burnout among providers and low success rates.
The COVID-19 pandemic shed light on accuracy of diagnoses via telehealth, with studies finding a high concordance rate between telehealth visits without the benefit of a physical exam, and in-person pain management consultant, which is similar to that found in other specialties. The proliferation of AI in electronic medical record systems that confer diagnoses based on patient and physician input of symptoms and signs suggests that in the future, patients with access to the information will be able to self-diagnose their chronic pain and other conditions. Many guidelines also recommend education and self-care in their back pain treatment algorithms, though the effect of education on outcomes is not well-known.
With this in mind, the purpose of this study is to determine how accurate patient diagnoses are when they are furnished with readily available information on the different etiologies for chronic low back pain (LBP), the leading cause of disability worldwide.
The plan is to enroll 269 patients in a 3:1 allocation ratio to either the 27-slide educational group or a condensed 4-slide control group. The patient will have the opportunity to ask questions, after which they will rate their top 2 diagnoses, in order. A trainee (resident or fellow) and the attending will do then do the same. Outcomes will be recorded at 4 weeks (e.g., for simple injections such as epidural steroids and sacroiliac joint injections, medications, physical therapy) or at 12 weeks for more invasive procedures such as spinal cord stimulation, radiofrequency ablation, or vertebral augmentation.
Analyses will be performed to: 1) Determine whether the educational program improves the likelihood that the patient correctly self-diagnoses the cause of their back pain using the attending physician as the reference standard compared to the control group; and 2) Whether the educational program improves treatment outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Pain Management Center
-
-
Washington
-
Seattle, Washington, United States, 98105
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Age > 18 years
- Primary complaint of LBP or sciatica
- Duration of LBP > 3 months
Exclusion Criteria:
• Referral for a specific diagnostic procedure or who present with a pre-established diagnosis
- Inability to understand written English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Education
Educational initiative on back pain
|
Patients will review 28 slides that discuss the different etiologies (causes) of back pain, how common they are, what causes them (e.g., wear and tear, trauma), factors that exacerbate and alleviate the pain, how they are diagnosed and treated, and have an opportunity to ask questions.
|
|
Active Comparator: Control
Control initiative (non-comprehensive overview)
|
Brief 4-slide presentation without a separate session for questions and answers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concordance
Time Frame: Day 0 (enrollment date)
|
Concordance (overlap) between the patient's guess at their top 2 diagnoses, and those rendered by the attending physician.
The patient's choices include 12 diagnoses (e.g., discogenic pain, spinal stenosis, piriformis syndrome) while the physician's includes 13 (secondary gain).
|
Day 0 (enrollment date)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concordance
Time Frame: Day 0
|
Concordance (overlap) between the patient's guess at their top 2 diagnoses, and those rendered by the trainee. The patient's choices include 12 diagnoses (e.g., discogenic pain, spinal stenosis, piriformis syndrome) while the physician's includes 13 (secondary gain). The intended scale is:
|
Day 0
|
|
Average back pain score
Time Frame: 6 weeks
|
Average back pain score over past week on a 0-10 numerical rating scale (higher scores indicating greater pain)
|
6 weeks
|
|
Worst back pain score
Time Frame: 6 weeks
|
Worst back pain score over past week on a 0-10 numerical rating scale (higher scores indicating greater pain)
|
6 weeks
|
|
Average leg pain score
Time Frame: 6 weeks
|
Average leg pain score over past week on a 0-10 numerical rating scale (higher scores indicating greater pain)
|
6 weeks
|
|
Worst leg pain score
Time Frame: 6 weeks
|
Worst leg pain score over past week on a 0-10 numerical rating scale (higher scores indicating greater pain)
|
6 weeks
|
|
Patient Global Impression of Change (PGIC) scale
Time Frame: 6 weeks
|
7-point Likert scale (7 is best outcome) in which patient rates their improvement as: no change or worse (1); almost the same (2); a little better (3); somewhat better (4); moderately better (5); better (6); a great deal better (7)
|
6 weeks
|
|
Successful outcome
Time Frame: 6 weeks
|
Greater or equal to 30% decrease in average back or leg (for sciatica) pain score coupled with a score >4 out of 7 on the Patient Global Impression of Change (PGIC) scale.
For patients with <4 average pain score, we will use "worst" pain score as the baseline reference.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HRP-593/ v11102023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.